Table 1 |
|||
| Pharmacokinetic parameters of DHA | |||
| Parameters | DHA N/O/W emulsion | DHA O/W emulsion | DHA solution |
| t1/2α (min) | 9.40 ± 0.28*,** | 3.97 ± 0.34 | 3.10 ± 0.09 |
| t1/2β (min) | 160.91 ± 47.21*,** | 73.31 ± 1.61* | 20.20 ± 6.56 |
| Cl (ml·min−1·kg) | 0.0023 ± 0.0002*,** | 0.0038 ± 0.0002* | 0.0069 ± 0.0013 |
| AUC (min·ng·ml−1) | 219,759.00 ± 14,782.77*,** | 131,564.5 ± 8,396.89* | 73,025.35 ± 14,149.00 |
| MRT (min) | 97.65 ± 20.27*,** | 32.22 ± 4.03* | 9.40 ± 2.44 |
Parameters of DHA after intravenous administration of DHA N/O/W emulsion to rabbits, DHA solution, and DHA O/W emulsion as controls. The results are expressed as mean ± S.D. (n = 6), *P < 0.01 vs. DHA solution, **P < 0.01 vs. DHA O/W emulsion.
Wang et al. Nanoscale Research Letters 2012 7:219 doi:10.1186/1556-276X-7-219